At the upcoming meeting of the American Urology Association in San Diego, two experts in the field of urology will discuss the role new molecular biomarkers will play in the diagnosis and staging of prostate cancer.
The ConfirmMDx test from MDx Health, Irvine, Calif, helps urologists rule out prostate cancer-free men from undergoing unnecessary repeat biopsies.
About the presentation:
“Understanding How New Biomarkers Will Assist in the Diagnosis and Prognosis of Prostate Cancer”
Presenters: E. David Crawford, MD, Head Section of Urologic Oncology, professor of urology, surgery, and radiation oncology, University of Colorado School of Medicine, Denver, and Neal D. Shore, MD, FACS, director, CPI, Carolina Urologic Research Center, Grand Strand Urology/Atlantic Urology Clinics, Myrtle Beach, SC
Date: May 7
Time: 10 am
Location: Industry Theatre, Exhibit Hall, San Diego Convention Center
Click here for more information about the presentation.